Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy
Genetic variants of SARS-CoV-2 have been emerging and circulating in many places across the world. Rapid detection of these variants is essential since their dissemination can impact transmission rates, diagnostic procedures, disease severity, response to vaccines or patient management. Sanger seque...
Gespeichert in:
Veröffentlicht in: | Genomics (San Diego, Calif.) Calif.), 2021-11, Vol.113 (6), p.4109-4115 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4115 |
---|---|
container_issue | 6 |
container_start_page | 4109 |
container_title | Genomics (San Diego, Calif.) |
container_volume | 113 |
creator | Dorlass, Erick Gustavo Lourenço, Karine Lima Magalhães, Rubens Daniel Miserani Sato, Hugo Fiorini, Alex Peixoto, Renata Coelho, Helena Perez Telezynski, Bruna Larotonda Scagion, Guilherme Pereira Ometto, Tatiana Thomazelli, Luciano Matsumiya Oliveira, Danielle Bruna Leal Fernandes, Ana Paula Durigon, Edison Luiz Fonseca, Flavio Guimarães Teixeira, Santuza Maria Ribeiro |
description | Genetic variants of SARS-CoV-2 have been emerging and circulating in many places across the world. Rapid detection of these variants is essential since their dissemination can impact transmission rates, diagnostic procedures, disease severity, response to vaccines or patient management. Sanger sequencing has been used as the preferred approach for variant detection among circulating human immunodeficiency and measles virus genotypes. Using primers to amplify a fragment of the SARS-CoV-2 genome encoding part of the Spike protein, we showed that Sanger sequencing allowed us to rapidly detect the introduction and spread of three distinct SARS-CoV-2 variants in two major Brazilian cities. In both cities, after the predominance of variants closely related to the virus first identified in China, the emergence of the P.2 variant was quickly followed by the detection of the P1 variant, which became dominant in less than one month after it was first detected.
•Detection of genetic variants of SARS-CoV-2.•Sanger Sequencing of SARS-CoV-2 variants.•Three distinct SARS-CoV-2 variants detected in two Brazilian cities.•Comparison of Sanger sequencing and Next Generation Sequencing. |
doi_str_mv | 10.1016/j.ygeno.2021.10.015 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8552628</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0888754321003785</els_id><sourcerecordid>2591218566</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-492a954a6d41eb19d96f228dd02d4fe94750d4aa7cafd529f873c8f2ce084b2c3</originalsourceid><addsrcrecordid>eNp9kU1vEzEQhi0EoqHwC5CQj1w2tb32xj6A1EZAkSohEeBqOfZ4cbSxi70btPDncUip4MJppJl33vl4EHpOyZIS2l3slnMPMS0ZYbRmloSKB2hBiVSN7Hj3EC2IlLJZCd6eoSel7AghqpXsMTpr-YpK2tIF-rmZ8gFmnDzeXH7cNOv0pWG4-sIYLHbhALmEccYh4vF7wnuzSxlfZfMjDMFEbMMYoOCphNhjg70pIzbRYeN9ys5sB8AbE3vIuMC3CaI96sqYzQj9_BQ98mYo8OwunqPPb998Wl83Nx_evV9f3jSWCzU2XDGjBDed4xS2VDnVecakc4Q57kHxlSCOG7OyxjvBlJer1krPLBDJt8y25-j1yfd22u7BWYh1gUHf5rA3edbJBP1vJYavuk8HLYVgHZPV4OWdQU71ijLqfSgWhsFESFPRTCjKqBRdV6XtSWpzKiWDvx9DiT5i0zv9G5s-YjsmK7ba9eLvDe97_nCqglcnAdQ_HQJkXWyo7wQXMthRuxT-O-AXKESs-A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2591218566</pqid></control><display><type>article</type><title>Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Dorlass, Erick Gustavo ; Lourenço, Karine Lima ; Magalhães, Rubens Daniel Miserani ; Sato, Hugo ; Fiorini, Alex ; Peixoto, Renata ; Coelho, Helena Perez ; Telezynski, Bruna Larotonda ; Scagion, Guilherme Pereira ; Ometto, Tatiana ; Thomazelli, Luciano Matsumiya ; Oliveira, Danielle Bruna Leal ; Fernandes, Ana Paula ; Durigon, Edison Luiz ; Fonseca, Flavio Guimarães ; Teixeira, Santuza Maria Ribeiro</creator><creatorcontrib>Dorlass, Erick Gustavo ; Lourenço, Karine Lima ; Magalhães, Rubens Daniel Miserani ; Sato, Hugo ; Fiorini, Alex ; Peixoto, Renata ; Coelho, Helena Perez ; Telezynski, Bruna Larotonda ; Scagion, Guilherme Pereira ; Ometto, Tatiana ; Thomazelli, Luciano Matsumiya ; Oliveira, Danielle Bruna Leal ; Fernandes, Ana Paula ; Durigon, Edison Luiz ; Fonseca, Flavio Guimarães ; Teixeira, Santuza Maria Ribeiro</creatorcontrib><description>Genetic variants of SARS-CoV-2 have been emerging and circulating in many places across the world. Rapid detection of these variants is essential since their dissemination can impact transmission rates, diagnostic procedures, disease severity, response to vaccines or patient management. Sanger sequencing has been used as the preferred approach for variant detection among circulating human immunodeficiency and measles virus genotypes. Using primers to amplify a fragment of the SARS-CoV-2 genome encoding part of the Spike protein, we showed that Sanger sequencing allowed us to rapidly detect the introduction and spread of three distinct SARS-CoV-2 variants in two major Brazilian cities. In both cities, after the predominance of variants closely related to the virus first identified in China, the emergence of the P.2 variant was quickly followed by the detection of the P1 variant, which became dominant in less than one month after it was first detected.
•Detection of genetic variants of SARS-CoV-2.•Sanger Sequencing of SARS-CoV-2 variants.•Three distinct SARS-CoV-2 variants detected in two Brazilian cities.•Comparison of Sanger sequencing and Next Generation Sequencing.</description><identifier>ISSN: 0888-7543</identifier><identifier>EISSN: 1089-8646</identifier><identifier>DOI: 10.1016/j.ygeno.2021.10.015</identifier><identifier>PMID: 34718131</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Brazil - epidemiology ; China ; Cities ; COVID-19 - epidemiology ; COVID-19 - virology ; genetic variants ; Genetic Variation ; High-Throughput Nucleotide Sequencing - methods ; Humans ; Mutation ; Phylogeny ; Sanger sequencing ; Sars-Cov-2 ; SARS-CoV-2 - genetics ; Spike ; Spike Glycoprotein, Coronavirus - genetics</subject><ispartof>Genomics (San Diego, Calif.), 2021-11, Vol.113 (6), p.4109-4115</ispartof><rights>2021</rights><rights>Copyright © 2021. Published by Elsevier Inc.</rights><rights>2021 Published by Elsevier Inc. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-492a954a6d41eb19d96f228dd02d4fe94750d4aa7cafd529f873c8f2ce084b2c3</citedby><cites>FETCH-LOGICAL-c459t-492a954a6d41eb19d96f228dd02d4fe94750d4aa7cafd529f873c8f2ce084b2c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0888754321003785$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34718131$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dorlass, Erick Gustavo</creatorcontrib><creatorcontrib>Lourenço, Karine Lima</creatorcontrib><creatorcontrib>Magalhães, Rubens Daniel Miserani</creatorcontrib><creatorcontrib>Sato, Hugo</creatorcontrib><creatorcontrib>Fiorini, Alex</creatorcontrib><creatorcontrib>Peixoto, Renata</creatorcontrib><creatorcontrib>Coelho, Helena Perez</creatorcontrib><creatorcontrib>Telezynski, Bruna Larotonda</creatorcontrib><creatorcontrib>Scagion, Guilherme Pereira</creatorcontrib><creatorcontrib>Ometto, Tatiana</creatorcontrib><creatorcontrib>Thomazelli, Luciano Matsumiya</creatorcontrib><creatorcontrib>Oliveira, Danielle Bruna Leal</creatorcontrib><creatorcontrib>Fernandes, Ana Paula</creatorcontrib><creatorcontrib>Durigon, Edison Luiz</creatorcontrib><creatorcontrib>Fonseca, Flavio Guimarães</creatorcontrib><creatorcontrib>Teixeira, Santuza Maria Ribeiro</creatorcontrib><title>Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy</title><title>Genomics (San Diego, Calif.)</title><addtitle>Genomics</addtitle><description>Genetic variants of SARS-CoV-2 have been emerging and circulating in many places across the world. Rapid detection of these variants is essential since their dissemination can impact transmission rates, diagnostic procedures, disease severity, response to vaccines or patient management. Sanger sequencing has been used as the preferred approach for variant detection among circulating human immunodeficiency and measles virus genotypes. Using primers to amplify a fragment of the SARS-CoV-2 genome encoding part of the Spike protein, we showed that Sanger sequencing allowed us to rapidly detect the introduction and spread of three distinct SARS-CoV-2 variants in two major Brazilian cities. In both cities, after the predominance of variants closely related to the virus first identified in China, the emergence of the P.2 variant was quickly followed by the detection of the P1 variant, which became dominant in less than one month after it was first detected.
•Detection of genetic variants of SARS-CoV-2.•Sanger Sequencing of SARS-CoV-2 variants.•Three distinct SARS-CoV-2 variants detected in two Brazilian cities.•Comparison of Sanger sequencing and Next Generation Sequencing.</description><subject>Brazil - epidemiology</subject><subject>China</subject><subject>Cities</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 - virology</subject><subject>genetic variants</subject><subject>Genetic Variation</subject><subject>High-Throughput Nucleotide Sequencing - methods</subject><subject>Humans</subject><subject>Mutation</subject><subject>Phylogeny</subject><subject>Sanger sequencing</subject><subject>Sars-Cov-2</subject><subject>SARS-CoV-2 - genetics</subject><subject>Spike</subject><subject>Spike Glycoprotein, Coronavirus - genetics</subject><issn>0888-7543</issn><issn>1089-8646</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1vEzEQhi0EoqHwC5CQj1w2tb32xj6A1EZAkSohEeBqOfZ4cbSxi70btPDncUip4MJppJl33vl4EHpOyZIS2l3slnMPMS0ZYbRmloSKB2hBiVSN7Hj3EC2IlLJZCd6eoSel7AghqpXsMTpr-YpK2tIF-rmZ8gFmnDzeXH7cNOv0pWG4-sIYLHbhALmEccYh4vF7wnuzSxlfZfMjDMFEbMMYoOCphNhjg70pIzbRYeN9ys5sB8AbE3vIuMC3CaI96sqYzQj9_BQ98mYo8OwunqPPb998Wl83Nx_evV9f3jSWCzU2XDGjBDed4xS2VDnVecakc4Q57kHxlSCOG7OyxjvBlJer1krPLBDJt8y25-j1yfd22u7BWYh1gUHf5rA3edbJBP1vJYavuk8HLYVgHZPV4OWdQU71ijLqfSgWhsFESFPRTCjKqBRdV6XtSWpzKiWDvx9DiT5i0zv9G5s-YjsmK7ba9eLvDe97_nCqglcnAdQ_HQJkXWyo7wQXMthRuxT-O-AXKESs-A</recordid><startdate>20211101</startdate><enddate>20211101</enddate><creator>Dorlass, Erick Gustavo</creator><creator>Lourenço, Karine Lima</creator><creator>Magalhães, Rubens Daniel Miserani</creator><creator>Sato, Hugo</creator><creator>Fiorini, Alex</creator><creator>Peixoto, Renata</creator><creator>Coelho, Helena Perez</creator><creator>Telezynski, Bruna Larotonda</creator><creator>Scagion, Guilherme Pereira</creator><creator>Ometto, Tatiana</creator><creator>Thomazelli, Luciano Matsumiya</creator><creator>Oliveira, Danielle Bruna Leal</creator><creator>Fernandes, Ana Paula</creator><creator>Durigon, Edison Luiz</creator><creator>Fonseca, Flavio Guimarães</creator><creator>Teixeira, Santuza Maria Ribeiro</creator><general>Elsevier Inc</general><general>Published by Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211101</creationdate><title>Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy</title><author>Dorlass, Erick Gustavo ; Lourenço, Karine Lima ; Magalhães, Rubens Daniel Miserani ; Sato, Hugo ; Fiorini, Alex ; Peixoto, Renata ; Coelho, Helena Perez ; Telezynski, Bruna Larotonda ; Scagion, Guilherme Pereira ; Ometto, Tatiana ; Thomazelli, Luciano Matsumiya ; Oliveira, Danielle Bruna Leal ; Fernandes, Ana Paula ; Durigon, Edison Luiz ; Fonseca, Flavio Guimarães ; Teixeira, Santuza Maria Ribeiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-492a954a6d41eb19d96f228dd02d4fe94750d4aa7cafd529f873c8f2ce084b2c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Brazil - epidemiology</topic><topic>China</topic><topic>Cities</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 - virology</topic><topic>genetic variants</topic><topic>Genetic Variation</topic><topic>High-Throughput Nucleotide Sequencing - methods</topic><topic>Humans</topic><topic>Mutation</topic><topic>Phylogeny</topic><topic>Sanger sequencing</topic><topic>Sars-Cov-2</topic><topic>SARS-CoV-2 - genetics</topic><topic>Spike</topic><topic>Spike Glycoprotein, Coronavirus - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dorlass, Erick Gustavo</creatorcontrib><creatorcontrib>Lourenço, Karine Lima</creatorcontrib><creatorcontrib>Magalhães, Rubens Daniel Miserani</creatorcontrib><creatorcontrib>Sato, Hugo</creatorcontrib><creatorcontrib>Fiorini, Alex</creatorcontrib><creatorcontrib>Peixoto, Renata</creatorcontrib><creatorcontrib>Coelho, Helena Perez</creatorcontrib><creatorcontrib>Telezynski, Bruna Larotonda</creatorcontrib><creatorcontrib>Scagion, Guilherme Pereira</creatorcontrib><creatorcontrib>Ometto, Tatiana</creatorcontrib><creatorcontrib>Thomazelli, Luciano Matsumiya</creatorcontrib><creatorcontrib>Oliveira, Danielle Bruna Leal</creatorcontrib><creatorcontrib>Fernandes, Ana Paula</creatorcontrib><creatorcontrib>Durigon, Edison Luiz</creatorcontrib><creatorcontrib>Fonseca, Flavio Guimarães</creatorcontrib><creatorcontrib>Teixeira, Santuza Maria Ribeiro</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Genomics (San Diego, Calif.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dorlass, Erick Gustavo</au><au>Lourenço, Karine Lima</au><au>Magalhães, Rubens Daniel Miserani</au><au>Sato, Hugo</au><au>Fiorini, Alex</au><au>Peixoto, Renata</au><au>Coelho, Helena Perez</au><au>Telezynski, Bruna Larotonda</au><au>Scagion, Guilherme Pereira</au><au>Ometto, Tatiana</au><au>Thomazelli, Luciano Matsumiya</au><au>Oliveira, Danielle Bruna Leal</au><au>Fernandes, Ana Paula</au><au>Durigon, Edison Luiz</au><au>Fonseca, Flavio Guimarães</au><au>Teixeira, Santuza Maria Ribeiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy</atitle><jtitle>Genomics (San Diego, Calif.)</jtitle><addtitle>Genomics</addtitle><date>2021-11-01</date><risdate>2021</risdate><volume>113</volume><issue>6</issue><spage>4109</spage><epage>4115</epage><pages>4109-4115</pages><issn>0888-7543</issn><eissn>1089-8646</eissn><abstract>Genetic variants of SARS-CoV-2 have been emerging and circulating in many places across the world. Rapid detection of these variants is essential since their dissemination can impact transmission rates, diagnostic procedures, disease severity, response to vaccines or patient management. Sanger sequencing has been used as the preferred approach for variant detection among circulating human immunodeficiency and measles virus genotypes. Using primers to amplify a fragment of the SARS-CoV-2 genome encoding part of the Spike protein, we showed that Sanger sequencing allowed us to rapidly detect the introduction and spread of three distinct SARS-CoV-2 variants in two major Brazilian cities. In both cities, after the predominance of variants closely related to the virus first identified in China, the emergence of the P.2 variant was quickly followed by the detection of the P1 variant, which became dominant in less than one month after it was first detected.
•Detection of genetic variants of SARS-CoV-2.•Sanger Sequencing of SARS-CoV-2 variants.•Three distinct SARS-CoV-2 variants detected in two Brazilian cities.•Comparison of Sanger sequencing and Next Generation Sequencing.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34718131</pmid><doi>10.1016/j.ygeno.2021.10.015</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0888-7543 |
ispartof | Genomics (San Diego, Calif.), 2021-11, Vol.113 (6), p.4109-4115 |
issn | 0888-7543 1089-8646 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8552628 |
source | MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals |
subjects | Brazil - epidemiology China Cities COVID-19 - epidemiology COVID-19 - virology genetic variants Genetic Variation High-Throughput Nucleotide Sequencing - methods Humans Mutation Phylogeny Sanger sequencing Sars-Cov-2 SARS-CoV-2 - genetics Spike Spike Glycoprotein, Coronavirus - genetics |
title | Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T13%3A21%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Survey%20of%20SARS-CoV-2%20genetic%20diversity%20in%20two%20major%20Brazilian%20cities%20using%20a%20fast%20and%20affordable%20Sanger%20sequencing%20strategy&rft.jtitle=Genomics%20(San%20Diego,%20Calif.)&rft.au=Dorlass,%20Erick%20Gustavo&rft.date=2021-11-01&rft.volume=113&rft.issue=6&rft.spage=4109&rft.epage=4115&rft.pages=4109-4115&rft.issn=0888-7543&rft.eissn=1089-8646&rft_id=info:doi/10.1016/j.ygeno.2021.10.015&rft_dat=%3Cproquest_pubme%3E2591218566%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2591218566&rft_id=info:pmid/34718131&rft_els_id=S0888754321003785&rfr_iscdi=true |